PG
MYGN icon

PEAK6 Group’s Myriad Genetics MYGN Stock Holding History

PEAK6 Group’s Portfolio MYGN Stock Details MYGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q2 		$1.27M Buy
+34,100
New +$1.15M 0.01% 1756
2018
Q1 		– Sell
-4,300
Closed -$148K – 4723
2017
Q4 		$148K Sell
4,300
-28,200
-87% -$951K ﹤0.01% 3339
2017
Q3 		$1.18M Sell
32,500
-86,000
-73% -$2.45M 0.01% 1822
2017
Q2 		$3.06M Buy
118,500
+84,900
+253% +$1.8M 0.02% 1027
2017
Q1 		$645K Buy
33,600
+18,900
+129% +$335K 0.01% 2042
2016
Q4 		$245K Sell
14,700
-41,500
-74% -$751K ﹤0.01% 3174
2016
Q3 		$1.16M Buy
56,200
+4,900
+10% +$124K 0.01% 1652
2016
Q2 		$1.57M Buy
51,300
+44,000
+603% +$1.53M 0.01% 1435
2016
Q1 		$273K Sell
7,300
-29,000
-80% -$1.09M ﹤0.01% 2847
2015
Q4 		$1.57M Sell
36,300
-251,100
-87% -$10.6M 0.01% 1549
2015
Q3 		$10.8M Buy
287,400
+260,200
+957% +$9.23M 0.06% 439
2015
Q2 		$925K Buy
27,200
+17,000
+167% +$578K 0.01% 2164
2015
Q1 		$361K Sell
10,200
-8,900
-47% -$319K ﹤0.01% 2883
2014
Q4 		$651K Buy
19,100
+9,000
+89% +$319K ﹤0.01% 2337
2014
Q3 		$390K Buy
10,100
+7,000
+226% +$261K ﹤0.01% 2705
2014
Q2 		$121K Sell
3,100
-35,000
-92% -$1.3M ﹤0.01% 3594
2014
Q1 		$1.3M Buy
+38,100
New +$1.18M 0.01% 1630
2013
Q3 		– Sell
-9,800
Closed -$263 – 5338
2013
Q2 		$263 Buy
+9,800
New +$284K ﹤0.01% 3376

Other funds holding MYGN

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Thrivent Financial for Lutherans
Thrivent Financial for Lutherans Minneapolis, Minnesota $52.5B AUM 27.12% 1-Year Est. Return
FCM
Frontier Capital Management Boston, Massachusetts $9.73B AUM 55.65% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

PEAK6 Group's MYGN Position: Q2 2018 in Review

PEAK6 Group sold out of Myriad Genetics (MYGN) in Q2 2018, closing a stake of 8,392 shares — an estimated $283K sold.

PEAK6 Group first reported a position in MYGN in Q2 2013 and held it in 5 quarters. The position peaked at $314K in Q4 2017. 258 funds tracked by Wall St. Rank hold MYGN as of Q2 2018.

  • PEAK6 Group reported no remaining Myriad Genetics position as of Q2 2018 after selling out during the quarter.
  • PEAK6 Group sold 8,392 Myriad Genetics shares in Q2 2018, an estimated $283K.
  • PEAK6 Group first reported a position in Myriad Genetics in Q2 2013 and held it in 5 quarters.
  • PEAK6 Group's Myriad Genetics position peaked at $314K in Q4 2017.
  • 258 funds tracked by Wall St. Rank held Myriad Genetics as of Q2 2018.

Based on PEAK6 Group's 13F filing for Q2 2018, filed 15 Aug 2018.